Encapsulation of biomaterials in porous glass-like matrices...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S006120, C436S527000

Reexamination Certificate

active

06303290

ABSTRACT:

FIELD OF THE INVENTION
The invention relates to the process of preparing a porous, inorganic, glass-like matrix by an alcohol-free, aqueous colloidal sol-gel process, and the encapsulation therein of an active biological material, and to the nanocomposite prepared by such processes, and to the qualitative and quantitative detection of a test substance in a gas or aqueous solution when it is brought into contact with the encapsulated active biomaterial in the nanocomposite.
BACKGROUND OF THE INVENTION
Biological molecules such as proteins, biopolymers, and enzymes including cytochrome c, catalase, ferriten, antibiotics, myoglobin, hemoglobin, and the like have been encapsulated into porous, inorganic host matrices, including transparent glasses and/or oxides (Bescher and Mackenzie,
Mat. Sci. Eng
., C6:145-154 (1998); Messing,
Immobilized Enzymes for Industrial Reactors
, Academic Press, New York (1975)). The metal alkoxide based process is the conventional choice for preparing an inorganic/organic hybrid at low temperatures (Klein,
Annual Review of Materials Science
, p. 227, Huggins et al., ed., Vol.15, (Palo Alto Calif.), 1985; Brinker and Scherer,
Sol
-
Gel Science: The Physics and Chemistry of Sol
-
Gel Processing
, Academic, Boston, 1990). The fragile characteristics of protein biomolecules limit the synthesis of inorganic/biomolecule composites to a sol-gel process for encapsulating the biological material into transparent silica matrices, which are capable of responding at a temperature significantly below the conventional sintering or melting temperature of the inorganics (Ellerby et al.,
Science
255:1113-15 (1992)); U.S. Pat. No. 5,200,334 (“Dunn et al. '334 patent”)).
The basic concept of the sol-gel process involves hydrolysis and polymerization of inorganic monomers, typically using metal alkoxides, such as tetramethyl orthosilicate (TMOS) or tetraethyl orthosilicate (TEOS). The biomolecules are added to and dispersed within the solution, to which a buffer solution has been introduced to adjust the solution pH to a level suitable for biomolecule survival. Hydrolysis of the alkoxide, e.g., TMOS, in the presence of water, an organic solvent and an acid/base catalyst results in the formation of —Si—OH bond. As the metal oxides undergo hydrolysis and polymerization reactions, the —Si—OH, silanol bonds further polymerize into —Si—O—Si— bonds, and an inorganic three-dimensional network finally develops within a firm gel. As the gel dries, it shrinks and hardens further into an inorganic matrix (sometimes referred to as an aerogel) with a pore size typically in the range of 2-5 nm. The residue solvents are expelled from the growing network and the dispersed biomolecules are finally trapped into network cages (Dave et al.,
Ana. Chem
. 66[22]:1120A-1127A (1994)). After a relatively long period of time, e.g., a few weeks, the solvent evaporates to result in a biomolecule-doped, transparent, dried matrix (Ellerby et al., 1992).
The biological molecules entrapped within the matrices reportedly retain high-levels of biological activity (Ellerby et a., 1992; Miller et al.,
J. Non-Crystalline Solids
202:279-289 (1996); Narang et aL,
Ana. Chem
66[19]:3139 (1994); Livage et al., J. Sol-Gel Sci. Tech. 7:45-51 (1996); Coche-Guerente et at.,
Chem. Alater
. 9: 1348-52 (1997); Kurokawa et al.,
Biotech. Bioengineer
. 42:394-397 (1993); Glezer and Lev,
J. Am. Chem. Soc
. 115:2533-34 (1993); Tatsu et at.,
Chem. Letters
1615-1618 (1992); Lan et al.,
J. Sol-Gel Sci. Tech
. 7:109-116 (1996)). Presumably, this is because the native-state conformation of the encapsulated molecule is sufficiently retained to permit a degree of measurable activity. Meanwhile, the matrix pores allow the diffusion of reactant molecules and their reaction with the entrapped biomolecules. Through these reactions, the biomolecule-containing inorganic monolith materials possess an ability to detect other molecules, and can thus be used as sensors for optical, electrical, mechanical or chemical signals (Bescher and Mackenzie,1998; Bakul et al.,
Ana. Chem
. 66[22]:1121A (1994)).
Both the gel and aerogel are typically, to a certain extent, transparent to visible light and permeable to gases, wetting agents, ions and small molecules. Thus, the structure and properties of encapsulated biomolecules can be examined via spectroscopic means. Unfortunately, however, although reports have indicated the successful retention of up to 80% of the protein activity, the presence of alcohol in these alkoxide-based sol-gel processes has been known to denature proteins, thereby causing chain unfolding, aggregation, and destruction of secondary and tertiary protein structures to a significant extent (Miller et al.,
J. Non-Crystalline Solids
202:279-289 (1996)).
Alcohol is known to be lethal to many higher level biomolecules that have more delicate structures and more complicated functions, and it may impair the activity of other biomolecules to some extent even when they survive. Although the TMOS method by Ellerby et al., 1992 and the Dunn et al. '334 patent claim to use a “non-alcoholic medium,” and teach that the addition of alcohol is not necessary to form the sol, any use of a metal alkoxide will release alcohol during hydrolysis. For example, in the case of TMOS, methanol is released according to the following reaction: Si(OMe)
4
+H
2
O→Si(OMe)
4−
+(OH)
x
+x CH
3
OH.
In the preceding reaction, Me represents the CH
3
group. The methanol (CH
3
OH) content, x, increases with the extent of hydrolysis. When hydrolysis is complete, a maximum of 4 moles of methanol is released for every mole of TMOS hydrolyzed. Since hydrolysis is the basis of the TMOS sol-gel method taught by Ellerby et al., 1992 and by the Dunn et al.'334 patent, alcohol always exists in the composite once the hydrolysis reaction begins. This is easily verified by the smell of alcohol that always accompanies any product of an alkoxide reaction, even though no alcohol has been expressly added.
The damaging effect of alcohol in the process is clear. For example, Miller et al., 1996, have reported a 70% reduction of the enzymatic activity when bovine liver catalase was encapsulated into a TMOS-based silica matrix, with merely 5 vol% methanol present. Moreover, a number of spectroscopic studies on protein denaturation have found an altered intensity and longwave shift of the absorption spectra when polar perturbing solvents, such as alcohols, interact with the aromatic amino acid residues of the proteins (Herkovits and Sorensen,
Biochemistry,
7:2523-2533 and 2533-2542 (1968); Izumi and Inoue,
J. Biochem
. (Tokyo), 79, 1309-1321 (1976); Timasheff and Inoue,
Biochemistry
, 7:2501-2513 (1968); and Strickland et al.,
Biochemistry
11:3657-3662 (1972)).
Accordingly, until the present invention, there has been a long-felt need in the art for the development of an alcohol-free, sol-gel process for the encapsulation of active, biological materials in a visually transparent porous, inorganic matrix, thereby preventing the denaturation of biomolecule caused by the undesirable interaction with the alcohol molecules and the extent of conformational change reduced, particularly for fragile biomolecules.
SUMMARY OF THE INVENTION
The present invention, therefore, meets a particular need in the art by providing an alcohol-free, aqueous, colloidal sol-gel process for the encapsulation of active, biological materials in a preferably visually transparent matrix. The proteins or biomolecules are immobilized, but they retain their biofunctions, reacting with incoming ions or solutions that diffuse through the porous matrix. Such reactions are often readily detectable by the change in the optical absorption resulting in a change of color. Therefore, these composites can be used as biosensors for gas and liquid species.
A similar class of hybrid composites incorporating enzymes and other biopolymers can be used for bioreactors for energy generation and other reactions. The encapsulated biomolecules may

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Encapsulation of biomaterials in porous glass-like matrices... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Encapsulation of biomaterials in porous glass-like matrices..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Encapsulation of biomaterials in porous glass-like matrices... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2604334

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.